Frequency and the risk factors of ICU-AW after critical illness
Not Applicable
Recruiting
- Conditions
- ICU acquired weakness
- Registration Number
- JPRN-UMIN000030471
- Lead Sponsor
- Sapporo Medical University School of Medicene, Department of Intensive Care Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who didn't got agreement on this study The patients judged as inappropriate enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the rate of ICU-AW and the time when nerve conduction study has changed
- Secondary Outcome Measures
Name Time Method prognosis(ICU, 28day, 90day, hospital mortality) inflamatory biomarker(CRP, Procalcitonin, Presepsin) Plasma cytokine(IL-1, IL-4, IL-6, IL-8, IL-10, IFN-gamma, TNF-alpha) Steroid, Immunoglobulin, Sedatives day of the beginning of rehabilitation, period of rehabilitation